Trials / Withdrawn
WithdrawnNCT01003405
Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder
A Open-label, Long-term Extension Study of KUC-7483 in Patients With Overactive Bladder
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the long-term safety, efficacy and pharmacokinetics of KUC-7483 in patients with overactive bladder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KUC-7483 |
Timeline
- First posted
- 2009-10-28
- Last updated
- 2010-07-27
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01003405. Inclusion in this directory is not an endorsement.